IO Biotech's cancer vaccine Cylembio failed to hit the mark in a phase 3 melanoma trial – but the company hopes to file for approval regardless. The company said that the study "narrowly missed" the ...
The demise of Metropolitan Capital Bank & Trust on Jan. 30 marked the first bank failure of 2026 and the 15th since November 2019. The Federal Deposit Insurance Corp. took over the $261.1 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results